期刊文献+

当归藤的化学成分研究 被引量:12

Study on Chemical Constituents of Embelia parviflora Wall.
下载PDF
导出
摘要 目的:研究广西壮族和瑶族民间常用药材当归藤的化学成分,为开发利用当归藤药材资源提供实验支持。方法:乙醇回流提取当归藤药材,浓缩成浸膏,用系统溶剂分离法萃取得到不同极性的当归藤提取部位,然后用硅胶柱层析法对石油醚部位进行分离纯化,得到的单体成分通过波谱方法进行鉴定。结果:从石油醚部位分离得到4个化合物,经结构鉴定其中的两个分别是豆甾醇(Ⅱ)、维生素E(Ⅲ)。结论:这两个化合物均为首次从当归藤中分离得到。 Objective A Study on the Chemical Constituents of Traditional Chinese Medicine of Embelia parviflora Wall. To pro- vide the experimental data for the better development and utilization of Chinese medicinal materials. Methods Firstly, pre - test the chemical composition of Embelia parviflora Wall. Then use the system solvent extraction separation method to get a different polarity of the extraction site, separation and purification of petroleum ether and ethyl acetate with silica gel column Chromatography method. Then use of the MS, 1H - NMR and 13 C - NMR technology for structural identification of compounds. In addition, also analyze the dif- ferent parts of the volatile oils by GC - MS. Results and Results Isolated and purified 4 compounds from Circumfluence extraction method of petroleum ether. Respectively is Stigmasterol and Vitamin E. Conclusion This is the first time that compaund of chemical compound were isdated from Embelia parviflora wall.
作者 阙祖亮 刘鼎 陈勇 张昕 魏江存 庞丹清 QUE Zuliang LIU Ding CHEN Yong ZHANG Xin WEI Jiangcun PANG Danqing(Guangxi University of Chinese Medicine, Nanning 530001, China)
出处 《中国民族民间医药》 2017年第5期5-9,共5页 Chinese Journal of Ethnomedicine and Ethnopharmacy
基金 国家自然科学基金委地区基金项目(编号:81660701) 广西民族药当归藤补血活血作用机制与主要化学成分研究 广西自然科学基金项目(桂科计字[2016]380号) 广西高校中药提取纯化与质量分析重点实验室(桂教科研[2014]6号) 壮瑶药协同创新中心(桂教科研[2013]20号)
关键词 当归藤 化学成分 壮药 瑶药 Embelia parviflora Wall Chemical Constituents Zhuang Medicine Yao Medicine
  • 相关文献

参考文献4

二级参考文献22

  • 1James P M, Ntozi. Impact of HIV/AIDS on fertility in subsaharan Africa [J ]. African Population Studies/Etude de la Population Africaine, 2002,17 ( 1 ) : 103-124.
  • 2Stephen E H, Chandra A. Use of infertility services in the United States1995 [J]. Fam Plann Perspect, 2000,32 ( 3 ) : 132-137.
  • 3Hirsh A. Male subfertility [J]. BMJ,2003,327(7416) :669-672.
  • 4Jorma T, Anne M H, Markku A. Changes in male reproductive health and effects of endocrine disruptor in Scandinavian countries [ J ]. Cad Satide P6blica Riode Janeiro, 2002, 18 (2) :413-420.
  • 5Che Y, Cleland J. Infertility in Shanghai: prevalence,treatment seeking and impact [J ]. Journal of Obstetrics & Gynaecology, 2002,22 (6) : 643- 648.
  • 6Liu J, Larsen U, Wyshak G. Prevalence of primary infertility in China: in-depth analysis of infertility differentials in three minority province/autonomous regions[ J ]. J Biosoc Sci, 2005,37(1):55-74.
  • 7Patricia D P. Infertility in the modern world: present and future prospects[J]. Family Practice,2001,18(4) :469.
  • 8Lok I H, Cheung L P , Haines C J. Management of infertility[J]. The Hong Kong Practitioner,2003,25:249-261.
  • 9Donova B. Rising prevalence of genital Chlamydia trachomatis infection in heterosexual patients at the Sydney Sexual Health Centre, 1994 to 2000[J]. Commun Dis Intell, 2002,26 ( 1 ) : 51-55.
  • 10Gdoura R, Keskes A L. Bouzid F, et al. Chlamydia trachomatis and male infertility in Tunisia [J]. The European Journal of Contraception and Reproductive Health Care.2001,6(2) : 102-107.

共引文献135

同被引文献114

引证文献12

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部